Bayer Aktiengesellschaft (ETR:BAYN)
28.08
-0.33 (-1.16%)
Nov 17, 2025, 10:35 AM CET
Bayer Aktiengesellschaft Revenue
Bayer Aktiengesellschaft had revenue of 9.66B EUR in the quarter ending September 30, 2025, a decrease of -3.09%. This brings the company's revenue in the last twelve months to 45.87B, down -1.87% year-over-year. In the year 2024, Bayer Aktiengesellschaft had annual revenue of 46.61B, down -2.16%.
Revenue (ttm)
45.87B
Revenue Growth
-1.87%
P/S Ratio
0.61
Revenue / Employee
518.25K
Employees
91,864
Market Cap
27.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 46.61B | -1.03B | -2.16% |
| Dec 31, 2023 | 47.64B | -3.10B | -6.11% |
| Dec 31, 2022 | 50.74B | 6.66B | 15.10% |
| Dec 31, 2021 | 44.08B | 2.68B | 6.48% |
| Dec 31, 2020 | 41.40B | -2.15B | -4.93% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.45B |
| Merck KGaA | 21.27B |
| Fresenius Medical Care AG | 19.64B |
| Sartorius Aktiengesellschaft | 3.52B |
| Redcare Pharmacy NV | 2.82B |
| Fielmann Group AG | 2.42B |
| Carl Zeiss Meditec AG | 2.18B |
Bayer Aktiengesellschaft News
- 2 days ago - Siemens Warns Currency Headwinds Will Hit 2026 Results; CEO Defends Mid-Term Target - Benzinga
- 4 days ago - Bayer Aktiengesellschaft (BAYRY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Bayer AG (BAYRY) Q3 2025 Earnings Call Highlights: Strong EPS Growth Amid Market Challenges - GuruFocus
- 4 days ago - Agricultural Conglomerate Bayer Confident In Long-Term Outlook Despite Litigation Risks - Benzinga
- 4 days ago - Agricultural Conglomerate Bayer Confident In Long-Term Outlook Despite Litigation Risks - Benzinga
- 4 days ago - Q3 2025 Bayer AG Earnings Call Transcript - GuruFocus
- 4 days ago - Bayer Q3 Earnings Beat Estimates on Crop Science Business Gains - Nasdaq
- 4 days ago - Bayer Aktiengesellschaft 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha